BPG is committed to discovery and dissemination of knowledge
Retrospective Study
©The Author(s) 2026.
World J Gastrointest Oncol. Jan 15, 2026; 18(1): 112742
Published online Jan 15, 2026. doi: 10.4251/wjgo.v18.i1.112742
Table 8 Comparison of target exposure achievement rates between different dosing regimens
Patient population
Traditional regimen achievement rate (%)
Optimized regimen achievement rate (%)
χ2
P value
Drug dosage change (%)
Sarcopenia group71.493.85.6820.017+14.2
Non-sarcopenia group87.793.21.1240.289-6.8
Overall82.093.56.8240.009+2.4


Write to the Help Desk